RYVIX | VENAX | RYVIX / VENAX | |
Total Expense Ratio | 1.42 | 0.09 | 1,578% |
Annual Report Gross Expense Ratio | 1.45 | 0.09 | 1,611% |
Fund Existence | 27 years | 21 years | - |
Gain YTD | -16.601 | -0.881 | 1,884% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.35M | 8.78B | 0% |
Annual Yield % from dividends | 0.00 | 3.19 | - |
Returns for 1 year | -23.27 | -5.20 | 447% |
Returns for 3 years | 0.23 | 11.08 | 2% |
Returns for 5 years | 53.79 | 133.80 | 40% |
Returns for 10 years | -61.34 | 23.92 | -256% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DRECX | 40.00 | 0.18 | +0.45% |
Davis Real Estate C | |||
MSEGX | 61.13 | -0.01 | -0.02% |
Morgan Stanley Inst Growth A | |||
CADRX | 24.06 | -0.04 | -0.17% |
Columbia Large Cap Growth Opp Inst2 | |||
RLEFX | 37.42 | -0.09 | -0.24% |
American Funds American Balanced R5E | |||
ADRRX | 21.75 | -0.07 | -0.32% |
American Century Disciplined Growth R |